Health
Decipher Test Clinically Validated as a Predictor of Overall Survival in Men with Prostate Cancer – PRNewswire
/PRNewswire/ — Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, with a focus in urologic oncology…
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ — Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, with a focus in urologic oncology specific to prostate and bladder cancers, today announced publication of the results, in JAMA Oncology, from an analysis of the NRG Oncology Phase 3 randomized controlled trial RTOG 96-01. In this study, the Decipher Prostate RP, a radical prostatectomy post-surgery test, was clinically validated to predict overall survival…
-
Noosa News15 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News21 hours agoQueensland Rail retires iconic electric train fleet after more than four decades
-
Business17 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth
-
Noosa News17 hours agoAustralia’s biggest sheep drive, and the young drover history forgot